FdaApplication
ANDA 202219
Identifiers
- fda_app_no: ANDA202219
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING LLC |
| application_type | ANDA |
| approval_date | 2012-08-08 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LITHIUM CARBONATE | LITHIUM CARBONATE | 450MG | TABLET, EXTENDED RELEASE;ORAL |
1 product